GluSense said yesterday that it received a $2 million grant from the Juvenile Diabetes Research Foundation’s T1D fund for the company’s injectable glucose sensor. Israel-based GluSense, part of Rainbow Medical, is developing the Glyde continuous glucose monitor for patients with Type I diabetes. The device is injected under the skin and lasts for 1 year, […]
Rainbow Medical said today that it inked a deal with a unit of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes to co-develop a minimally invasive implant to treat degenerative disc disease. The deal between Medos International and Rainbow calls for development work to be carried out both in Israel and the U.S., including pre-clinical trials and laboratory tests, Herzliya, […]
February 16, 2015 by Brad Perriello
Rainbow Medical said yesterday that it pulled down $25 million from a syndicate of Chinese investors for a new operation in the People’s Republic, aimed at promoting "strategic collaborations" there.
Sohn, whose resignation was effective March 31, was still listed on Imaging3’s website today. The company agreed to pay out $9,100 in severance, according to the filing.